Trial Profile
Phase III trial investigating the efficacy of fibroblast growth factor-1 [CVBT 141B] in patients with diabetic wounds
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 02 Apr 2020
Price :
$35
*
At a glance
- Drugs Fibroblast growth factor 1 (Primary)
- Indications Diabetic complications; Diabetic foot ulcer; Wounds
- Focus Registrational; Therapeutic Use
- Sponsors Venturis Therapeutics
- 04 Feb 2011 New trial record